AGGARWAL GAURAV reported 1 transaction at UNICYCIVE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/19/2025ACC: 0001213900-25-015152
Director
Since Mar 2023
+1.40M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.40M acquired · 686.00 disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+1.40M
Price / share
—
Trade value
—
% of position
14.0%
2/18/2025
9.97M→11.37M
Total
Net shares
+1.40M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/18/2025 | C · Conversion | +1.40M | — | — | 14.0% | 9.97M | 11.37M |
| Total | +1.40M | $0.00 | ||||||
Derivative Transactions1
Series A-2 Prime Preferred Stock
Indirect
Converts to
Common Stock
1.40M shares
Shares
−686.00
Strike price
0.49
Held after
3.12K
Exercisable
—
2/18/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A-2 Prime Preferred Stock Indirect | Common Stock1.40M shares | 2/18/2025 | D · Disposition | −686.00 | 0.49 | — | 3.12K |